Molecular heterogeneity in breast carcinoma cells with increased invasive capacities.
Saved in:
| Title: | Molecular heterogeneity in breast carcinoma cells with increased invasive capacities. |
|---|---|
| Authors: | Negro G; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria.; EORTC PathoBiology Group Brussels, Belgium., Aschenbrenner B; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria.; EORTC PathoBiology Group Brussels, Belgium., Brezar SK; Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Cemazar M; Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.; University of Primorska, Faculty of Health Sciences, Izola, Slovenia.; EORTC PathoBiology Group Brussels, Belgium., Coer A; University of Primorska, Faculty of Health Sciences, Izola, Slovenia.; Orthopaedic Hospital Valdoltra, Ankaran, Slovenia., Gasljevic G; Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Savic D; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria.; EORTC PathoBiology Group Brussels, Belgium., Sorokin M; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.; I.M. Sechenov First Moscow State Medical University, Moscow, Russia.; Omicsway Corp.,Walnut, USA.; EORTC PathoBiology Group Brussels, Belgium., Buzdin A; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.; I.M. Sechenov First Moscow State Medical University, Moscow, Russia.; Oncobox ltd.,Moscow, Russia.; EORTC PathoBiology Group Brussels, Belgium., Callari M; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.; EORTC PathoBiology Group Brussels, Belgium., Kvitsaridze I; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria.; EORTC PathoBiology Group Brussels, Belgium., Jewett A; Division of Oral Biology and Medicine Microbiology, Immunology, & Molecular Genetics, Tumor Immunology Laboratory, College of Letters & Science, UCLA School of Dentistry and Medicine, Los Angeles, USA., Vasileva-Slaveva M; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria.; EORTC PathoBiology Group Brussels, Belgium., Ganswindt U; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria., Skvortsova I; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria.; EORTC PathoBiology Group Brussels, Belgium., Skvortsov S; Medical University of Innsbruck, Therapeutic Radiology and Oncology, Innsbruck, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria. |
| Source: | Radiology and oncology [Radiol Oncol] 2020 Feb 14; Vol. 54 (1), pp. 103-118. Date of Electronic Publication: 2020 Feb 14. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Sciendo Country of Publication: Poland NLM ID: 9317213 Publication Model: Electronic Cited Medium: Internet ISSN: 1581-3207 (Electronic) Linking ISSN: 13182099 NLM ISO Abbreviation: Radiol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1581-3207 |
|---|---|
| DOI: | 10.2478/raon-2020-0007 |
